![]() |
Volumn 50, Issue 4, 2009, Pages 433-441
|
Differential hypertensive therapy according to the guidelines;Leitliniengerechte differenzialtherapie der hypertonie
|
Author keywords
Combination therapy; First choice antihypertensive drugs; Life style changes; Monotherapy; Target blood pressure
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ATENOLOL;
BENAZEPRIL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CAPTOPRIL;
CHLORTALIDONE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
HYDROCHLOROTHIAZIDE;
INDAPAMIDE;
IRBESARTAN;
LOSARTAN;
METHYLDOPA;
METOPROLOL;
PERINDOPRIL;
PLACEBO;
TELMISARTAN;
THIAZIDE DIURETIC AGENT;
VASODILATOR AGENT;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
BLOOD PRESSURE REGULATION;
BRONCHOSPASM;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
COUGHING;
DIABETIC NEUROPATHY;
EMBRYOTOXICITY;
ESSENTIAL HYPERTENSION;
FETOTOXICITY;
FLUSHING;
GLUCOSE INTOLERANCE;
HEADACHE;
HUMAN;
HYPERKALEMIA;
HYPERURICEMIA;
HYPOKALEMIA;
LIFESTYLE MODIFICATION;
MONOTHERAPY;
PRACTICE GUIDELINE;
SIDE EFFECT;
WEIGHT GAIN;
ANTIHYPERTENSIVE AGENTS;
CARDIOLOGY;
GERMANY;
HUMANS;
HYPERTENSION;
PRACTICE GUIDELINES AS TOPIC;
|
EID: 67349264857
PISSN: 00209554
EISSN: None
Source Type: Journal
DOI: 10.1007/s00108-008-2292-8 Document Type: Article |
Times cited : (4)
|
References (29)
|